Fibrinolysis Pathway Components

The fibrinolysis pathway comprises a coordinated set of enzymes, receptors, inhibitors, and substrate proteins primarily responsible for breaking down fibrin clots formed during the coagulation process. Key elements include plasminogen (the inactive zymogen), its activators (tPA and uPA), their receptors (such as uPAR), substrate proteins (fibrinogen, fibrin), and inhibitors (PAI-1, α2-antiplasmin). Targeted therapeutic modulation (via activators, inhibitors, or molecules interfering with protein–protein interactions) is employed in diverse clinical scenarios, including acute thrombotic events, bleeding diatheses, and chronic cardiovascular or inflammatory diseases. The system’s complexity—with extensive protein–protein interactions and involvement in multiple physiological and pathological states—means no single “fibrinolysis pathway component” serves as a canonical therapeutic target, but several individual molecules within the pathway are drug targets.

Other names

Fibrinolytic systemcomponents of fibrinolytic cascadefibrinolytic proteinsfibrinolytic pathway factors

Activation or inhibition of plasminogen-to-plasmin conversion; Direct proteolysis of fibrin clots; Inhibition of plasmin activity; Blockade of plasminogen activators or inhibitors (e.g., PAI-1 inhibition); Modulation of uPA/uPAR activity; Modulation of fibrin contraction and clot structure